CClinicalTrials.gg
Status unknownNCT02279264Updated Oct 31, 2014

Product Validation Study of RightSpot Infant pH Indicator for Rapid Bedside Verification of Proper Nasogastric (NG) Tube Placement in Newborn Intensive Care (NICU) Patients

An observational study in Establish Normative pH Values in Neonates, sponsored by RightBio Metrics. Status unknown at 1 site in United States. Open to participants aged 24 Weeks to 40 Weeks. Per ClinicalTrials.gov, last updated 2014-10-31.

Sponsored by RightBio Metrics · Observational

The sponsor has not verified this record recently (last verified Oct 2014), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
40
Ages
24 Weeks to 40 Weeks
Sex
All
01

Study summary

Objectives:

  1. To validate the accuracy of pH measurements of gastric fluid by comparing the readings from the RightSpot Infant pH Indicator to a standard clinically approved pH monitor
  2. To determine what percentage of time the RightSpot Infant pH Indicator could have been used to determine the proper placement of the NG tube prior to feedings
  3. To establish normative pH values for neonates
Read the detailed description

RightBio Metrics has developed an indicator that rapidly checks gastric pH by aspirating gastric contents into the indicator through a nasogastric (NG) or orogastric (OG), causing a color change on the indicator. The color change represents various pH levels. Most Newborn Intensive Care Units require that NG/OG placement be confirmed after initial insertion and prior to any use. The purpose of this study is to validate the accuracy of pH measurement of gastric fluid by comparing the reading from the RightSpot Infant pH Indicator to a standard clinically approved pH monitor, and to determine what percentage of time the RightSpot Infant pH Indicator could have been used to determine the proper placement of the NG/OG tube prior to use. The gastric pH measurements will be analyzed to determine the normative pH values for neonates.

02

Conditions studied

  • Establish Normative pH Values in Neonates

Keywords

  • ph
  • RightSpot Infant
  • Feeding Tube
  • RightBio Metrics
  • placement
  • Nasogastric Tube
  • NG
  • infant
03

In context

Lead sponsor

RightBio Metrics is the lead sponsor of 2 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
24 Weeks to 40 Weeks
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Infants in the Newborn Intensive Care Unit with an NG Tube

Inclusion criteria

  • Infants in the Newborn Intensive Care Unit with an NG Tube

Exclusion criteria

Exclusion Criteria:

  • Infants with congenital or genetic abnormalities
  • Infants with gastroschesis
  • Infants with upper airway abnormalities
  • Infants receiving any supplement or medication know to alter pH gastric contents
  • Infants receiving Enfamil liquid human milk fortification
  • Infant who are NPO status
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
40 participants (estimated)
Patient registry
No

Interventions

  • DeviceRightSpot Infant pH Indicator

    pH indicator

    Also known as: RightBio Metrics, RSI001

06

What researchers measure

Primary outcomes

  1. To compare the gastric pH measurement obtained from the RightSpot Indicator to the gastric pH measurement obtained from an approved pH monitor to determine the agreement and accuracy of the two modes of measurements.

    Time frame: 12 weeks

  2. To determine the percentage of samples obtained by the RightSpot pH Indicator that could have been used to assist in determining proper placement of the NG tube prior to use. (% of collected samples vs. uncollected)

    Time frame: 12 weeks

  3. To determine the percentage of samples obtained by the RightSpot pH Indicator that could have been used in determining proper placement of the NG tube prior to use.(% of sample accuracy)

    Time frame: 12 weeks

  4. The gastric pH measurements will be collected and analyzed to determine the normative pH values for neonates

    Time frame: 12 weeks

Secondary outcomes

  1. Gestation age at birth

    Time frame: 12 weeks

  2. Adjusted gestational age at the time of testing

    Time frame: 12 weeks

  3. Infants weight at the time of testing

    Time frame: 12 weeks

  4. Time infant last ate

    Time frame: 12 weeks

  5. Residual amount (ml) at the time of testing

    Time frame: 12 weeks

  6. pH reading from gastric secretions

    Time frame: 12 weeks

  7. Medications given which effect pH of gastric contents

    Time frame: 12 weeks

07

Study locations

1 of 1 sites recruiting
  • Banner Good Samaritan
    Phoenix, Arizona 85014, United States
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 31, 2014, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02279264
Lead sponsor
RightBio Metrics
Responsible party
Sponsor
First posted
Oct 31, 2014
Start date
Sep 2014
Primary completion
Nov 2014 (estimated)
Last update
Oct 31, 2014

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Oct 2014. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion